Feed ARKG
AR

ARK Genomic Revolution ETF ARKG CBOE · Financials · United States

$41.16 -4.73% -$2.05

Summary

ARK Genomic Revolution ETF is an ETF - a fund traded on an exchange like a stock - run by ARK. Positions inside: 34. The ten largest make up 59% of the fund.

Yearly costs
0.75%
Fund size
$2.21B
Positions
34
Dividends
Reinvested
Running since
2014

What speaks for it

  • A large fund with $2.21B under management.
  • Easy to buy and sell: about $177.5M changes hands a day.
  • Average yearly growth over the last ten years: 8.6%.
  • It has been running since 2014.

What to watch

  • The ten largest positions make up 59% of the fund, so its result rests on a few names.
  • 96% of the fund is in one sector (Healthcare).
  • 92% of the fund is in one country (United States).
  • Costs of 0.75% a year are above the middle of comparable funds (0.45%).
  • In the last five years its price once dropped by 84% from its high.

A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.

Price

Performance

1 month
-7.5%
3 months
-0.6%
This year
+49%
1 year
+61%
3 years
+66%
5 years
-41%
10 years
+128%
Avg. market cap
$68.9B
P/E
-
Forward P/E
-
P/S
10.0x
P/B
5.3x
P/FCF
-
EV/EBITDA
-
Dividend yield
0.02%
ROIC
-20.2%
ROE
-29.2%
Gross margin
-129.5%
Operating margin
-809.2%
Net margin
-733.6%
Payout ratio
-
Net debt/EBITDA
-
Beta
2.38

Weighted average of the 33 largest companies, which make up 100% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.

What is inside?

Concentrated
  1. 1
    TE
    Tempus AI, Inc. TEM 11%
  2. 2
    TX
    10x Genomics, Inc. TXG 7.9%
  3. 3
    TW
    Twist Bioscience TWST 7.7%
  4. 4
    AB
    Absci Corporation ABSI 5.3%
  5. 5
    CR
    CRISPR Therapeutics CRSP 5.2%
  6. 6
    GH
    Guardant Health GH 4.9%
  7. 7
    LL
    Eli Lilly LLY 4.5%
  8. 8
    NT
    Natera NTRA 4.4%
  9. 9
    IL
    Illumina ILMN 4.3%
  10. 10
    BE
    Beam Therapeutics BEAM 4.0%

Positions in the fund: 34. The ten largest make up 59% of it.

Composition as of Nov 12, 2026.

Where is it spread?

One sector dominates

By sector

By country

By company size

By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.

Largest sector: Healthcare (96%). Largest country: United States (92%). Largest size group: Mid cap (34%).

What does it cost me?

Expensive
A year from $10,000
$75.00
Over 20 years
$3,544

From every $10,000 invested the fund takes $75.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $3,544.

How has it done?

Growing over the long run
A year on average, 10 years
+8.6%
Deepest drop
-84%
Yearly volatility
47%

Average yearly growth over the last ten years: 8.6%. Deepest drop in these years: 84% below the earlier high.

Does it pay dividends?

No, it reinvests

The fund pays nothing out. What its holdings earn stays inside and shows in the price.

Is it easy to buy and sell?

Very easy
Traded a day
$177.5M
Shares a day
4.3M

On an average day about $177.5M of the fund changes hands.

How expensive are the companies inside?

Rather expensive
Average Bulios Score
38 out of 100

Weight by Bulios Fair Price

By Fair Price, 92% of the rated weight comes out as overvalued.

Counted from its largest companies (33), which make up 100% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.

Similar funds

Funds that hold much of the same. The overlap says how much of their weight they share with this fund.

Fund Domicile Size 1-year change Dividends
HL
HLTH Tema Healthcare AI ETF
United States 0.75% $1.04M - - 39%
GN
GNOM Global X - Genomics & Biotechnology ETF
United States 0.50% $102.7M +43% Pays out 38%
GN
GNMX Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
United States 0.35% $1.91M - - 29%
AR
ARKK ARK Innovation ETF
United States 0.75% $7.52B -2.5% Reinvests 26%
HE
HELX Franklin Genomic Advancements ETF
United States 0.50% $34.0M +22% Pays out 25%
WD
WDNA WisdomTree BioRevolution Fund
United States 0.45% $2.93M +37% Pays out 24%

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy